Chrysin Pretreatment Improves Angiotensin System, cGMP Concentration in L-NAME Induced Hypertensive Rats
暂无分享,去创建一个
[1] H. Westerblad,et al. Dietary nitrate improves cardiac contractility via enhanced cellular Ca2+ signaling , 2016, Basic Research in Cardiology.
[2] S. Rajagopal,et al. Chrysin Ameliorates the Lipid Profiles in Nω-nitro-l-arginine-methylester-induced Hypertensive Rats , 2016 .
[3] M. Tate,et al. Exendin-4 attenuates adverse cardiac remodelling in streptozocin-induced diabetes via specific actions on infiltrating macrophages , 2015, Basic Research in Cardiology.
[4] Y. Kamisah,et al. Mechanisms of the antihypertensive effects of Nigella sativa oil in L-NAME-induced hypertensive rats , 2015, Clinics.
[5] R. Senthilkumar,et al. Chrysin enhances antioxidants and oxidative stress in L-NAME-induced hypertensive rats , 2015 .
[6] G. Archunan,et al. Effects on chrysin on lipid and xenobiotic metabolizing enzymes in l-NAME-induced hypertension , 2014 .
[7] M. Tanira,et al. Prehypertension: Underlying pathology and therapeutic options. , 2014, World journal of cardiology.
[8] B. Raja,et al. Valproic acid prevents the deregulation of lipid metabolism and renal renin-angiotensin system in L-NAME induced nitric oxide deficient hypertensive rats. , 2014, Environmental toxicology and pharmacology.
[9] T. Malarvili,et al. Effects of chrysin on free radicals and enzymatic antioxidants in Nω-nitro-l-arginine methyl ester: Induced hypertensive rats , 2014 .
[10] V. Ramanathan,et al. Role of chrysin on hepatic and renal activities of Nω-nitro-l-arginine-methylester induced hypertensive rats , 2014 .
[11] D. Sharma,et al. Novel diallyldisulfide analogs ameliorate cardiovascular remodeling in rats with L-NAME-induced hypertension. , 2012, European journal of pharmacology.
[12] M. Bilge,et al. Percutaneous renal denervation in patients with resistant hypertension-first experiences in Turkey. , 2012, Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology.
[13] C. Saldanha,et al. Hemorheological Effects of Valsartan in L-NAME Induced Hypertension in Rats , 2011 .
[14] W. Durante. Targeting heme oxygenase-1 in vascular disease. , 2010, Current drug targets.
[15] E. Kohner,et al. NADPH Oxidase versus Mitochondria-Derived ROS in Glucose-Induced Apoptosis of Pericytes in Early Diabetic Retinopathy , 2010, Journal of ophthalmology.
[16] P. Geraldine,et al. In-vitro antioxidant activities of an ethanolic extract of the oyster mushroom, Pleurotus ostreatus , 2009 .
[17] M. Ibarra-Barajas,et al. Angiotensin II augments renal vasoconstriction via AT1 receptors in L-NAME-induced hypertensive rats. , 2009, Proceedings of the Western Pharmacology Society.
[18] J. Tanus-Santos,et al. [Role of nitric oxide in the control of the pulmonary circulation: physiological, pathophysiological, and therapeutic implications]. , 2008, Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia.
[19] D. Ganten,et al. Update on tissue renin–angiotensin systems , 2008, Journal of Molecular Medicine.
[20] H. Sasamura,et al. Developmental Activity of the Renin-Angiotensin System during the “Critical Period” Modulates Later L-NAME–Induced Hypertension and Renal Injury , 2007, Hypertension Research.
[21] Jawed Alam,et al. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. , 2006, Physiological reviews.
[22] C. Adin,et al. Products of heme oxygenase and their potential therapeutic applications. , 2006, American journal of physiology. Renal physiology.
[23] S. Moncada,et al. The discovery of nitric oxide and its role in vascular biology , 2006, British journal of pharmacology.
[24] A. Fenning,et al. l-Arginine attenuates cardiovascular impairment in DOCA-salt hypertensive rats. , 2005, American journal of physiology. Heart and circulatory physiology.
[25] Takahiro Shimizu,et al. Calcium Channel Blockades Exhibit Anti-Inflammatory and Antioxidative Effects by Augmentation of Endothelial Nitric Oxide Synthase and the Inhibition of Angiotensin Converting Enzyme in the NG-Nitro-L-Arginine Methyl Ester-Induced Hypertensive Rat Aorta: Vasoprotective Effects beyond the Blood Press , 2005, Hypertension Research.
[26] Arantxa González,et al. Mechanisms of Disease: pathologic structural remodeling is more than adaptive hypertrophy in hypertensive heart disease , 2005, Nature Clinical Practice Cardiovascular Medicine.
[27] A. Vaandrager,et al. Signalling by cGMP-dependent protein kinases , 1996, Molecular and Cellular Biochemistry.
[28] S. Kim,et al. Upregulation of vascular renin-angiotensin and endothelin systems in rats inhibited of nitric oxide synthesis. , 2002, Pharmacological research.
[29] K. Weber,et al. Cardiac Fibrosis as a Cause of Diastolic Dysfunction , 2002, Herz.
[30] C. Rice-Evans,et al. Flavonoid antioxidants. , 2001, Current medicinal chemistry.
[31] S. Waldman,et al. Guanylyl cyclases and signaling by cyclic GMP. , 2000, Pharmacological reviews.
[32] P. Renard,et al. A convenient extension of the Wessely-Moser rearrangement for the synthesis of substituted alkylaminoflavones as neuroprotective agents in vitro. , 2000, Bioorganic & medicinal chemistry letters.
[33] P. Fuller,et al. Mineralocorticoid action , 2000, Steroids.
[34] T. Koike,et al. Effects of Chronic Nitric Oxide Synthase Inhibition on Renal Function and Histology in Polycythemic Rats , 1998, Kidney and Blood Pressure Research.
[35] J. Harborne,et al. Chrysin and other leaf exudate flavonoids in the genus Pelargonium. , 1997, Phytochemistry.
[36] A. Edwards. The pharmacology of inhaled nitric oxide. , 1995, Archives of disease in childhood. Fetal and neonatal edition.
[37] A. Deng,et al. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. , 1992, The Journal of clinical investigation.